Alpha Centric Advisors LLC Legend Biotech Corp Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
SELL
$38.15 - $57.1 $114,450 - $171,300
-3,000 Closed
0 $0
Q4 2021

Feb 25, 2022
BUY
$41.14 - $56.98 $123,420 - $170,940
3,000 New
3,000 $140,000
Q2 2021

Mar 09, 2022
SELL
$25.8 - $41.09 $516,000 - $821,800
-20,000 Closed
0 $0
Q1 2021

Mar 09, 2022
BUY
$23.55 - $32.4 $471,000 - $648,000
20,000 New
20,000 $580,000

Others Institutions Holding LEGN

# of Institutions
225
Shares Held
74.3M
Call Options Held
279K
Put Options Held
350K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.85B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email